Loading clinical trials...
Loading clinical trials...
Bronchiectasis was described in the early 19th century by Laennec. Bronchiectasis is a chronic condition characterized by permanent and irreversible dilatation of the bronchial airways and impairment ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Assiut University
NCT05045391 · Pulmonary Tuberculoses, Aspergillosis, and more
NCT07157904 · Tuberculosis, Pulmonary Tuberculoses, and more
NCT04930978 · COVID-19 Respiratory Infection, Pulmonary Tuberculoses
NCT04044001 · Pulmonary Tuberculoses, Other Specified Pulmonary Tuberculosis
NCT05017324 · Rifampicin Resistant Tuberculosis, Drug-resistant Tuberculosis, and more
Assiut unviresty
Asyut
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions